Ocugen, Inc. Made Big Gain

Ocugen, Inc. (OCGN:NASDAQ) shot up at $3.07, representing a gain of 67.8%. The stock appeared on our News Catalysts scanner on Fri 25 Dec 20 at 03:22 AM in the 'INVESTOR UPDATE' category. From Thu 17 Dec 20, the stock recorded 33.33% Up Days and 30.00% Green Days

The stock spiked on Wed 23 Dec 20 at $3.05 with a volume of 918M+.

About Ocugen, Inc. (OCGN:NASDAQ)

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).